M&A Deal Summary |
|
|---|---|
| Date | 2022-06-23 |
| Target | Radius Health |
| Sector | Life Science |
| Buyer(s) |
Patient Square Capital
Gurnet Point Capital |
| Deal Type | Going Private |
| Deal Value | 890M USD |
| Advisor(s) | J.P. Morgan Securities (Financial) Ropes & Gray (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Patient Square Capital is a private investment firm specializing in the healthcare sector. The Firm seeks opportunities to invest broadly across the healthcare industry, including technology-enabled services, biopharmaceuticals, the pharmaceutical value chain, medical devices, diagnostics, providers, digital health and consumer health. Patient Square Capital was formed in 2020 and is headquartered in Menlo Park, California.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 8 |
| Sector (Life Science) | 1 of 2 |
| Type (Going Private) | 2 of 4 |
| State (Massachusetts) | 1 of 1 |
| Country (United States) | 4 of 8 |
| Year (2022) | 3 of 5 |
| Size (of disclosed) | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-05-02 |
Enavate Sciences
Menlo Park, California, United States Enavate Sciences is a platform dedicated to supporting therapeutic companies advancing medicines and enabling technologies with transformative potential to address patient need. Through the application of capital support and operational experience, Enavate strives to enable and empower a diverse portfolio of therapeutics companies to accelerate innovation. Enavate Sciences is based in Menlo Park, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-06-27 |
Eargo
San Jose, California, United States Eargo is a consumer-focused medical device company that develops and sells hearing aids to assist people with hearing loss in the United States. The company sells its products through online stores. Eargo was formed in 2010 and is based in San Jose, California. |
Buy | - |
Gurnet Point Capital is private investment group focused on the healthcare and life sciences sectors. The Firm looks to invest across all stages of product development through to commercialization and does so with an approach that is a hybrid of venture and private equity investing strategies. Gurnet Point Capital was formed in 2015 and is headquartered in Cambridge, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 5 |
| Sector (Life Science) | 2 of 3 |
| Type (Going Private) | 3 of 4 |
| State (Massachusetts) | 1 of 2 |
| Country (United States) | 3 of 4 |
| Year (2022) | 1 of 1 |
| Size (of disclosed) | 1 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-10-11 |
Corium
Grand Rapids, Michigan, United States Corium is a commercial-stage biopharmaceutical company focused on the development, manufacture, and commercialization of specialty pharmaceutical products that leverage the company’s broad experience with advanced transdermal and transmucosal delivery systems. Corium was founded in 1995 and is based in Grand Rapids, Michigan. |
Buy | $504M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-06-06 |
Paratek Pharmaceuticals
Boston, Massachusetts, United States Paratek Pharmaceuticals is a bio-pharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in novel tetracycline chemistry. Paratek Pharmaceuticals was founded in 1996 and is based in Boston, Massachusetts. |
Buy | $462M |
